Use The Relay Innovation Engine (RIE) to optimize your pipeline portfolio. The Relay Innovation Engine can help pharmaceutical and biotech companies explore and evaluate potential licensing and acquisition opportunities – from discovery and pre-clinical to the clinical stages of development. Build out a strong development pipeline by:
Identifying new licensing opportunities:
- Unearth new technologies that have high probability of success.
- Objectively evaluate and discover assets in your target category, including assets located outside of the US.
Assessing the relative attractiveness of assets under consideration:
Weigh how licensing and M&A transactions, and clinical development milestones impact the potential of your target asset.
Avoiding transactions that have limited potential:
Track your current targets performance against others in the category and over time.
